臨床試験イメージングの市場規模、シェア、動向分析レポート：サービス別、モダリティ別、最終用途別、用途別、地域別、セグメント予測、2024年～2030年

臨床試験イメージング市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の臨床試験イメージング市場規模は、2024年から2030年にかけてCAGR 6.1％を記録し、2030年には19億7,000万米ドルに達すると予測されています。

慢性疾患を治療するための新薬や治療法を発見するための研究開発費の増加が、業界の成長を後押ししています。体内検査から得られる画像は、薬剤活性の判定に使用されます。臨床試験用画像は、迅速で詳細かつ正確なスクリーニングを提供します。臨床試験画像診断のニーズは、臨床試験のあらゆるフェーズで急速に高まっています。臨床試験における医用画像は、主要、定量的、代替バイオマーカーとして使用されます。

臨床試験デザインには、患者集団の選択、バイオマーカーに基づく層別化、治療割り付けのためのさまざまな方法、効率的で信頼性の高いエンドポイントの選択と代替エンドポイントの検証、サンプルサイズの計算、試験シミュレーション、適応試験セットアップ、統計解析、中間解析、EMAやFDAなどの規制当局と試験デザインについて議論したり試験結果を弁護したりするためのクライアントの対応支援などが含まれます。

市場開拓企業は、臨床開発強化のための分析試験サービス、薬物動態、読影、薬力学サービスを提供しています。IXICO社は、神経科学の臨床試験を促進する先進技術を提供しています。同社によるイメージングバイオマーカーは、神経イメージングに使用される治療法の安全性と有効性の測定に役立ちます。イメージングバイオマーカーは放射線学的読影に有効です。これにより、中枢神経用のMRIスキャンの読影が可能になり、薬剤の安全性と被験者の適格性に関する継続的なモニタリングの評価が強化されます。

臨床試験イメージング市場レポート・ハイライト

• プロジェクトおよびデータ管理サービス分野は、臨床試験イメージングにおけるデータ管理およびワークフローへの要求が高まっていることから、2023年に28.73%の最大収益シェアで市場を占めました。
• オペレーショナル・イメージング・サービス分野も大きな収益シェアで市場をリードし、2024年から2030年までのCAGRは7.32%と最も急速に成長すると予測され、MRI、CTスキャン、超音波、光コヒーレンストモグラフィ（OCT）、X線などの画像モダリティが含まれます。
• 2023年には、腫瘍分野が28.98％の最大収益シェアで市場を占めました。がん患者の高い有病率と、様々なタイプのがんを治療するための新しく革新的な治療法に対する絶え間ないニーズが、市場の成長を促進すると予想されています。
• 研究開発分野への投資の増加、コストと時間の削減を目的とした製薬・バイオテクノロジー企業によるアウトソーシング活動の雪だるま式増加、特許の失効などにより、2023年にはCRO（医薬品開発業務受託機関）分野が45.95％の最大収益シェアで市場をリードしました。
• 北米は、高齢者人口の増加、慢性疾患の増加、治療オプションの需要増により、2023年の売上高シェア40.73％で市場を独占しました。

目次

第1章 臨床試験イメージング市場：調査手法論と範囲

第2章 臨床試験イメージング市場：エグゼクティブサマリー

• 市場の見通し
• セグメントの見通し
• 競合考察

第3章 臨床試験イメージング市場：変数、動向、範囲

• 市場系統の見通し
• 普及と成長の見通しマッピング
• 業界のバリューチェーン分析
• 市場力学
• X線システム市場分析ツール

第4章 臨床試験イメージング市場：サービスの推定・動向分析

• 定義と範囲
• サービス市場シェア、2018年と2030年
• セグメントダッシュボード
• 製品別の世界の臨床試験イメージング市場の見通し
• 市場規模、予測および動向分析、2018年から2030年まで

第5章 臨床試験イメージング市場：モダリティの推定・動向分析

• 定義と範囲
• モダリティ市場シェア、2018年および2030年
• セグメントダッシュボード
• 臨床試験イメージング市場のモダリティ別展望
• 市場規模、予測および動向分析、2018年から2030年まで

第6章 臨床試験イメージング市場：アプリケーションの推定・動向分析

• 定義と範囲
• アプリケーション市場シェア、2018年および2030年
• セグメントダッシュボード
• 用途別臨床試験イメージング市場の見通し
• 市場規模、予測および動向分析、2018年から2030年まで

第7章 臨床試験イメージング市場：最終用途の推定・動向分析

• 定義と範囲
• 最終用途市場シェア、2018年および2030年
• セグメントダッシュボード
• 最終用途別の臨床試験イメージング市場の見通し
• 市場規模、予測および動向分析、2018年から2030年まで

第8章 臨床試験イメージング市場：地域推定・動向分析

• 地域市場シェア分析、2023年および2030年
• 地域市場ダッシュボード
• 世界の地域市場のスナップショット
• 市場規模と予測トレンド分析、2018年から2030年：
• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • スウェーデン
  • デンマーク
• アジア太平洋地域
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第9章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 会社/競合の分類
  • イノベーター
• ベンダー情勢
  • List of key distributors and channel partners
  • Key customers
  • Key company market share analysis, 2023
  • IXICO plc
  • Navitas Life Sciences
  • Resonance Health
  • ProScan Imaging
  • Radiant Sage LLC
  • Medpace
  • Biomedical Systems Corp.
  • Cardiovascular Imaging Technologies
  • Intrinsic Imaging
  • BioTelemetry

List of Tables

• Table 1 List of Abbreviation
• Table 2 North America clinical trial imaging market, by region, 2018 - 2030 (USD Million)
• Table 3 North America clinical trial imaging market, by service, 2018 - 2030 (USD Million)
• Table 4 North America clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
• Table 5 North America clinical trial imaging market, by application, 2018 - 2030 (USD Million)
• Table 6 North America clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
• Table 7 U.S. clinical trial imaging market, by service, 2018 - 2030 (USD Million)
• Table 8 U.S. clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
• Table 9 U.S. clinical trial imaging market, by application, 2018 - 2030 (USD Million)
• Table 10 U.S. clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
• Table 11 Canada clinical trial imaging market, by service, 2018 - 2030 (USD Million)
• Table 12 Canada clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
• Table 13 Canada clinical trial imaging market, by application, 2018 - 2030 (USD Million)
• Table 14 Canada clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
• Table 15 Europe clinical trial imaging market, by region, 2018 - 2030 (USD Million)
• Table 16 Europe clinical trial imaging market, by service, 2018 - 2030 (USD Million)
• Table 17 Europe clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
• Table 18 Europe clinical trial imaging market, by application, 2018 - 2030 (USD Million)
• Table 19 Europe clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
• Table 20 Germany clinical trial imaging market, by service, 2018 - 2030 (USD Million)
• Table 21 Germany clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
• Table 22 Germany clinical trial imaging market, by application, 2018 - 2030 (USD Million)
• Table 23 Germany clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
• Table 24 UK clinical trial imaging market, by service, 2018 - 2030 (USD Million)
• Table 25 UK clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
• Table 26 UK clinical trial imaging market, by application, 2018 - 2030 (USD Million)
• Table 27 UK clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
• Table 28 France clinical trial imaging market, by service, 2018 - 2030 (USD Million)
• Table 29 France clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
• Table 30 France clinical trial imaging market, by application, 2018 - 2030 (USD Million)
• Table 31 France clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
• Table 32 Italy clinical trial imaging market, by service, 2018 - 2030 (USD Million)
• Table 33 Italy clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
• Table 34 Italy clinical trial imaging market, by application, 2018 - 2030 (USD Million)
• Table 35 Italy clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
• Table 36 Spain clinical trial imaging market, by service, 2018 - 2030 (USD Million)
• Table 37 Spain clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
• Table 38 Spain clinical trial imaging market, by application, 2018 - 2030 (USD Million)
• Table 39 Spain clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
• Table 40 Sweden clinical trial imaging market, by service, 2018 - 2030 (USD Million)
• Table 41 Sweden clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
• Table 42 Sweden clinical trial imaging market, by application, 2018 - 2030 (USD Million)
• Table 43 Sweden clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
• Table 44 Denmark clinical trial imaging market, by service, 2018 - 2030 (USD Million)
• Table 45 Denmark clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
• Table 46 Denmark clinical trial imaging market, by application, 2018 - 2030 (USD Million)
• Table 47 Denmark clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
• Table 48 Norway clinical trial imaging market, by service, 2018 - 2030 (USD Million)
• Table 49 Norway clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
• Table 50 Norway clinical trial imaging market, by application, 2018 - 2030 (USD Million)
• Table 51 Norway clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
• Table 52 Asia Pacific clinical trial imaging market, by region, 2018 - 2030 (USD Million)
• Table 53 Asia Pacific clinical trial imaging market, by service, 2018 - 2030 (USD Million)
• Table 54 Asia Pacific clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
• Table 55 Asia Pacific clinical trial imaging market, by application, 2018 - 2030 (USD Million)
• Table 56 Asia Pacific clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
• Table 57 China clinical trial imaging market, by service, 2018 - 2030 (USD Million)
• Table 58 China clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
• Table 59 China clinical trial imaging market, by application, 2018 - 2030 (USD Million)
• Table 60 China clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
• Table 61 Japan clinical trial imaging market, by service, 2018 - 2030 (USD Million)
• Table 62 Japan clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
• Table 63 Japan clinical trial imaging market, by application, 2018 - 2030 (USD Million)
• Table 64 Japan clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
• Table 65 India clinical trial imaging market, by service, 2018 - 2030 (USD Million)
• Table 66 India clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
• Table 67 India clinical trial imaging market, by application, 2018 - 2030 (USD Million)
• Table 68 India clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
• Table 69 Australia clinical trial imaging market, by service, 2018 - 2030 (USD Million)
• Table 70 Australia clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
• Table 71 Australia clinical trial imaging market, by application, 2018 - 2030 (USD Million)
• Table 72 Australia clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
• Table 73 South Korea clinical trial imaging market, by service, 2018 - 2030 (USD Million)
• Table 74 South Korea clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
• Table 75 South Korea clinical trial imaging market, by application, 2018 - 2030 (USD Million)
• Table 76 South Korea clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
• Table 77 Thailand clinical trial imaging market, by service, 2018 - 2030 (USD Million)
• Table 78 Thailand clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
• Table 79 Thailand clinical trial imaging market, by application, 2018 - 2030 (USD Million)
• Table 80 Thailand clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
• Table 81 Latin America clinical trial imaging market, by region, 2018 - 2030 (USD Million)
• Table 82 Latin America clinical trial imaging market, by service, 2018 - 2030 (USD Million)
• Table 83 Latin America clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
• Table 84 Latin America clinical trial imaging market, by application, 2018 - 2030 (USD Million)
• Table 85 Latin America clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
• Table 86 Brazil clinical trial imaging market, by service, 2018 - 2030 (USD Million)
• Table 87 Brazil clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
• Table 88 Brazil clinical trial imaging market, by application, 2018 - 2030 (USD Million)
• Table 89 Brazil clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
• Table 90 Mexico clinical trial imaging market, by service, 2018 - 2030 (USD Million)
• Table 91 Mexico clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
• Table 92 Mexico clinical trial imaging market, by application, 2018 - 2030 (USD Million)
• Table 93 Mexico clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
• Table 94 Argentina clinical trial imaging market, by service, 2018 - 2030 (USD Million)
• Table 95 Argentina clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
• Table 96 Argentina clinical trial imaging market, by application, 2018 - 2030 (USD Million)
• Table 97 Argentina clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
• Table 98 Middle East and Africa clinical trial imaging market, by region, 2018 - 2030 (USD Million)
• Table 99 Middle East and Africa clinical trial imaging market, by service, 2018 - 2030 (USD Million)
• Table 100 Middle East and Africa clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
• Table 101 Middle East and Africa clinical trial imaging market, by application, 2018 - 2030 (USD Million)
• Table 102 Middle East and Africa clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
• Table 103 South Africa clinical trial imaging market, by service, 2018 - 2030 (USD Million)
• Table 104 South Africa clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
• Table 105 South Africa clinical trial imaging market, by application, 2018 - 2030 (USD Million)
• Table 106 South Africa clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
• Table 107 Saudi Arabia clinical trial imaging market, by service, 2018 - 2030 (USD Million)
• Table 108 Saudi Arabia clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
• Table 109 Saudi Arabia clinical trial imaging market, by application, 2018 - 2030 (USD Million)
• Table 110 Saudi Arabia clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
• Table 111 UAE clinical trial imaging market, by service, 2018 - 2030 (USD Million)
• Table 112 UAE clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
• Table 113 UAE clinical trial imaging market, by application, 2018 - 2030 (USD Million)
• Table 114 UAE clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
• Table 115 Kuwait clinical trial imaging market, by service, 2018 - 2030 (USD Million)
• Table 116 Kuwait clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
• Table 117 Kuwait clinical trial imaging market, by application, 2018 - 2030 (USD Million)
• Table 118 Kuwait clinical trial imaging market, by end use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Primary interviews in North America
• Fig. 5 Primary interviews in Europe
• Fig. 6 Primary interviews in APAC
• Fig. 7 Primary interviews in Latin America
• Fig. 8 Primary interviews in MEA
• Fig. 9 Market research approaches
• Fig. 10 Value-chain-based sizing & forecasting
• Fig. 11 QFD modeling for market share assessment
• Fig. 12 Market formulation & validation
• Fig. 13 clinical trial imaging market: market outlook
• Fig. 14 clinical trial imaging market competitive insights
• Fig. 15 Parent market outlook
• Fig. 16 Related/ancillary market outlook
• Fig. 17 Penetration and growth prospect mapping
• Fig. 18 Industry value chain analysis
• Fig. 19 Clinical trial imaging market driver impact
• Fig. 20 Clinical trial imaging market restraint impact
• Fig. 21 Clinical trial imaging market strategic initiatives analysis
• Fig. 22 Clinical trial imaging market: Service movement analysis
• Fig. 23 Clinical trial imaging market: Service outlook and key takeaways
• Fig. 24 Clinical trial design and consultation services market estimates and forecast, 2018 - 2030
• Fig. 25 Reading and analytical services market estimates and forecast, 2018 - 2030
• Fig. 26 Operational imaging services market estimates and forecast, 2018 - 2030
• Fig. 27 System and technology support services market estimates and forecast, 2018 - 2030
• Fig. 28 Project and data management market estimates and forecast, 2018 - 2030
• Fig. 29 Clinical trial imaging market: Modality movement analysis
• Fig. 30 Clinical trial imaging market: Modality outlook and key takeaways
• Fig. 31 Computed tomography market estimates and forecast, 2018 - 2030
• Fig. 32 Magnetic resonance imaging market estimates and forecast, 2018 - 2030
• Fig. 33 X-Ray market estimates and forecast, 2018 - 2030
• Fig. 34 Ultrasound market estimates and forecast, 2018 - 2030
• Fig. 35 Optical coherence tomography (OCT) market estimates and forecast, 2018 - 2030
• Fig. 36 Others market estimates and forecast, 2018 - 2030
• Fig. 37 Clinical trial imaging market: Application movement analysis
• Fig. 38 Clinical trial imaging market: Application outlook and key takeaways
• Fig. 39 NASH market estimates and forecast, 2018 - 2030
• Fig. 40 CKD market estimates and forecast, 2018 - 2030
• Fig. 41 Diabetes market estimates and forecast, 2018 - 2030
• Fig. 42 Cardiovascular diseases market estimates and forecast, 2018 - 2030
• Fig. 43 Ophthalmology market estimates and forecast, 2018 - 2030
• Fig. 44 Musculoskeletal market estimates and forecast, 2018 - 2030
• Fig. 45 Oncology market estimates and forecast, 2018 - 2030
• Fig. 46 Gastroenterology market estimates and forecast, 2018 - 2030
• Fig. 47 Pediatrics market estimates and forecast, 2018 - 2030
• Fig. 48 Others market estimates and forecast, 2018 - 2030
• Fig. 49 Clinical trial imaging market: End use movement analysis
• Fig. 50 Clinical trial imaging market: End use outlook and key takeaways
• Fig. 51 Biotechnology and Pharmaceutical companies market estimates and forecast, 2018 - 2030
• Fig. 52 Medical devices manufacturers market estimates and forecast, 2018 - 2030
• Fig. 53 Academic and government research institutes market estimates and forecast, 2018 - 2030
• Fig. 54 Contract research organizations (CROs) market estimates and forecast, 2018 - 2030
• Fig. 55 Others market estimates and forecast, 2018 - 2030
• Fig. 56 Global clinical trial imaging market: Regional movement analysis
• Fig. 57 Global clinical trial imaging market: Regional outlook and key takeaways
• Fig. 58 Global market shares and leading players
• Fig. 59 North America market share and leading players
• Fig. 60 Europe market share and leading players
• Fig. 61 Asia Pacific market share and leading players
• Fig. 62 Latin America market share and leading players
• Fig. 63 Middle East & Africa market share and leading players
• Fig. 64 North America
• Fig. 65 North America market estimates and forecast, 2018 - 2030
• Fig. 66 U.S.
• Fig. 67 U.S. market estimates and forecast, 2018 - 2030
• Fig. 68 Canada
• Fig. 69 Canada market estimates and forecast, 2018 - 2030
• Fig. 70 Europe
• Fig. 71 Europe. market estimates and forecast, 2018 - 2030
• Fig. 72 UK
• Fig. 73 UK market estimates and forecast, 2018 - 2030
• Fig. 74 Germany
• Fig. 75 Germany market estimates and forecast, 2018 - 2030
• Fig. 76 France
• Fig. 77 France market estimates and forecast, 2018 - 2030
• Fig. 78 Italy
• Fig. 79 Italy market estimates and forecast, 2018 - 2030
• Fig. 80 Spain
• Fig. 81 Spain market estimates and forecast, 2018 - 2030
• Fig. 82 Sweden
• Fig. 83 Sweden market estimates and forecast, 2018 - 2030
• Fig. 84 Denmark
• Fig. 85 Denmark market estimates and forecast, 2018 - 2030
• Fig. 86 Norway
• Fig. 87 Norway market estimates and forecast, 2018 - 2030
• Fig. 88 Asia Pacific
• Fig. 89 Asia Pacific market estimates and forecast, 2018 - 2030
• Fig. 90 China
• Fig. 91 China market estimates and forecast, 2018 - 2030
• Fig. 92 Japan
• Fig. 93 Japan market estimates and forecast, 2018 - 2030
• Fig. 94 India
• Fig. 95 India market estimates and forecast, 2018 - 2030
• Fig. 96 Australia
• Fig. 97 Australia market estimates and forecast, 2018 - 2030
• Fig. 98 South Korea
• Fig. 99 South Korea market estimates and forecast, 2018 - 2030
• Fig. 100 Thailand
• Fig. 101 Thailand market estimates and forecast, 2018 - 2030
• Fig. 102 Latin America
• Fig. 103 Latin America market estimates and forecast, 2018 - 2030
• Fig. 104 Brazil
• Fig. 105 Brazil market estimates and forecast, 2018 - 2030
• Fig. 106 Mexico
• Fig. 107 Mexico market estimates and forecast, 2018 - 2030
• Fig. 108 Argentina
• Fig. 109 Argentina market estimates and forecast, 2018 - 2030
• Fig. 110 Middle East and Africa
• Fig. 111 Middle East and Africa. market estimates and forecast, 2018 - 2030
• Fig. 112 Saudi Arabia
• Fig. 113 Saudi Arabia market estimates and forecast, 2018 - 2030
• Fig. 114 South Africa
• Fig. 115 South Africa market estimates and forecast, 2018 - 2030
• Fig. 116 UAE
• Fig. 117 UAE market estimates and forecast, 2018 - 2030
• Fig. 118 Kuwait
• Fig. 119 Kuwait market estimates and forecast, 2018 - 2030
• Fig. 120 Participant categorization- Clinical trial imaging market
• Fig. 121 Market share of key market players- Clinical trial imaging market

Clinical Trial Imaging Market Growth & Trends:

The global clinical trial imaging market size is expected to reach USD 1.97 billion by 2030, registering a CAGR of 6.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing research and development spending to discover new drugs and therapies to treat chronic diseases is propelling the industry growth. Images obtained from the internal examination of the body are used to determine drug activity. Clinical trial imaging provides rapid, detailed, and accurate screening. The need for clinical trial imaging is rapidly increasing in all phases of trials. Medical imaging in clinical trials is used as a primary, quantitative, and surrogate biomarker.

The clinical trial design includes selecting patient population, stratification based on biomarkers, different methods for allocation treatments, choosing efficient and reliable endpoints and validation of surrogate endpoints, calculating sample size, trial simulations, adaptive trial set-up, statistical and interim analysis, and assisting clients to deal with regulatory authorities such as EMA and FDA to discuss study design or defend study results.

Market players provide analytical testing services, pharmacokinetic, reading, and pharmacodynamics services for enhanced clinical development. IXICO offers advanced technologies for catalyzing clinical trials in neuroscience. Imaging biomarkers by the company help in measuring the safety and effectiveness of therapies used for neuro-imaging. Imaging biomarkers are effective in radiological reads. This provides the reading of MRI scans for central neuro to enhance the assessment of ongoing monitoring of drug safety and subject eligibility

Clinical Trial Imaging Market Report Highlights:

• The project and data management services segment held the market with the largest revenue share of 28.73% in 2023 due to the growing requirement for data management and workflow for clinical trial imaging
• The operational imaging services segment also led the market with significant revenue share and are projected to grow the fastest CAGR of 7.32% from 2024 to 2030 and include imaging modalities such as MRI, CT scan, Ultrasound, Optical Coherence Tomography (OCT), X-rays, and others
• The oncology segment held the market with the largest revenue share of 28.98% in 2023. High prevalence of cancer cases and the constant need for new and innovative therapies to treat various types of cancer are expected to fuel the market growth.
• The contract research organizations (CROs) segment led the market with the largest revenue share of 45.95% in 2023 due to increasing investments in the field of research and development, snowballing outsourcing activities by the pharmaceutical and biotechnology companies to cut down the cost and time, and patent expiration
• North America dominated the market with a revenue share of 40.73% in 2023 due to the increasing geriatric population, along with chronic diseases and growing demand for treatment options.

Table of Contents

Chapter 1. Clinical Trial Imaging Market: Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Service
  • 1.1.2. Modality
  • 1.1.3. Application
  • 1.1.4. End Use
  • 1.1.5. Regional scope
  • 1.1.6. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
    • 1.3.5.1. Data for primary interviews in North America
    • 1.3.5.2. Data for primary interviews in Europe
    • 1.3.5.3. Data for primary interviews in Asia Pacific
    • 1.3.5.4. Data for primary interviews in Latin America
    • 1.3.5.5. Data for Primary interviews in MEA
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.6.2. Volume price analysis (Model 2)
    • 1.6.2.1. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives
  • 1.9.1. Objective 1
  • 1.9.2. Objective 2

Chapter 2. Clinical Trial Imaging Market: Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Service outlook
  • 2.2.2. Modality outlook
  • 2.2.3. Application outlook
  • 2.2.4. End use outlook
  • 2.2.5. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Clinical Trial Imaging Market: Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Industry Value Chain Analysis
  • 3.3.1. Reimbursement framework
• 3.4. Market Dynamics
  • 3.4.1. Market driver analysis
    • 3.4.1.1. Growing number of pharmaceutical and biotechnological companies
    • 3.4.1.2. Growing number of contract research organization (CRO)
    • 3.4.1.3. Increasing research and development investments
  • 3.4.2. Market restraint analysis
    • 3.4.2.1. High cost of machineries and installations
• 3.5. X-ray Systems Market Analysis Tools
  • 3.5.1. Industry Analysis - Porter's
    • 3.5.1.1. Supplier power
    • 3.5.1.2. Buyer power
    • 3.5.1.3. Substitution threat
    • 3.5.1.4. Threat of new entrant
    • 3.5.1.5. Competitive rivalry
  • 3.5.2. PESTEL Analysis
    • 3.5.2.1. Political landscape
    • 3.5.2.2. Technological landscape
    • 3.5.2.3. Economic landscape
  • 3.5.3. Major Deals & Strategic Alliances Analysis
  • 3.5.4. Market Entry Strategies

Chapter 4. Clinical Trial Imaging Market: Service Estimates & Trend Analysis

• 4.1. Definitions and Scope
  • 4.1.1. Clinical Trial Design and Consultation Services
  • 4.1.2. Reading and Analytical Services
  • 4.1.3. Operational Imaging
    • 4.1.3.1. Computed Tomography (CT) Scan
    • 4.1.3.2. MRI (Magnetic Resonance Imaging)
    • 4.1.3.3. X-ray
    • 4.1.3.4. Ultrasound
    • 4.1.3.5. Optical Coherence Tomography (OCT)
    • 4.1.3.6. Others
  • 4.1.4. System and Technology Support Services
  • 4.1.5. Project and Data Management
• 4.2. Services Market Share, 2018 & 2030
• 4.3. Segment Dashboard
• 4.4. Global Clinical Trial Imaging Market by Product Outlook
• 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5.1. Clinical Trial Design and Consultation Services
    • 4.5.1.1. Clinical Trial Design and Consultation Services market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5.2. Reading and Analytical Services
    • 4.5.2.1. Reading and Analytical Services market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5.3. Operational Imaging Services
    • 4.5.3.1. Operational Imaging Services market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5.4. System and Technology Support Services
    • 4.5.4.1. System and Technology Support Services market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5.5. Project and Data Management
    • 4.5.5.1. Project and Data Management market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Clinical Trial Imaging Market: Modality Estimates & Trend Analysis

• 5.1. Definitions and Scope
  • 5.1.1. Computed Tomography
  • 5.1.2. Magnetic Resonance Imaging
  • 5.1.3. X-Ray
  • 5.1.4. Ultrasound
  • 5.1.5. Optical Coherence Tomography (OCT)
  • 5.1.6. Others
• 5.2. Modality Market Share, 2018& 2030
• 5.3. Segment Dashboard
• 5.4. Clinical Trial Imaging Market by Modality Outlook
• 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5.1. Computed Tomography
    • 5.5.1.1. Computed tomography estimates and forecast 2018 to 2030 (USD Million)
  • 5.5.2. Magnetic Resonance Imaging
    • 5.5.2.1. Magnetic resonance imaging estimates and forecast 2018 to 2030 (USD Million)
  • 5.5.3. X-Ray
    • 5.5.3.1. X-Ray market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5.4. Ultrasound
    • 5.5.4.1. Ultrasound market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5.5. Optical Coherence Tomography (OCT)
    • 5.5.5.1. Optical coherence tomography (OCT) market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5.6. Others
    • 5.5.6.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Clinical Trial Imaging Market: Application Estimates & Trend Analysis

• 6.1. Definitions and Scope
  • 6.1.1. Nonalcoholic Steatohepatitis (NASH)
  • 6.1.2. Chronic Kidney Disease (CKD)
  • 6.1.3. Diabetes
  • 6.1.4. Cardiovascular Diseases
  • 6.1.5. Ophthalmology
  • 6.1.6. Musculoskeletal
  • 6.1.7. Oncology
  • 6.1.8. Gastroenterology
  • 6.1.9. Pediatrics
  • 6.1.10. Others
• 6.2. Application Market Share, 2018& 2030
• 6.3. Segment Dashboard
• 6.4. Clinical Trial Imaging Market by Application Outlook
• 6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5.1. Nonalcoholic Steatohepatitis (NASH)
    • 6.5.1.1. Nonalcoholic steatohepatitis estimates and forecast 2018 to 2030 (USD Million)
  • 6.5.2. Chronic Kidney Disease
    • 6.5.2.1. Chronic kidney disease estimates and forecast 2018 to 2030 (USD Million)
  • 6.5.3. Diabetes
    • 6.5.3.1. Diabetes market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5.4. Cardiovascular Diseases
    • 6.5.4.1. Cardiovascular diseases market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5.5. Ophthalmology
    • 6.5.5.1. Ophthalmology market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5.6. Oncology
    • 6.5.6.1. Oncology market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5.7. Musculoskeletal
    • 6.5.7.1. Musculoskeletal market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5.8. Gastroenterology
    • 6.5.8.1. Gastroenterology market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5.9. Pediatrics
    • 6.5.9.1. Pediatrics market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5.10. Others
    • 6.5.10.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Clinical Trial Imaging Market: End Use Estimates & Trend Analysis

• 7.1. Definitions and Scope
  • 7.1.1. Biotechnology and Pharmaceutical Companies
  • 7.1.2. Medical Devices Manufacturers
  • 7.1.3. Academic and Government Research Institutes
  • 7.1.4. Contract Research Organization (CRO)
  • 7.1.5. Others
• 7.2. End Use Market Share, 2018 & 2030
• 7.3. Segment Dashboard
• 7.4. Clinical Trial Imaging Market by End Use Outlook
• 7.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 7.5.1. Biotechnology and Pharmaceutical Companies
    • 7.5.1.1. Biotechnology and pharmaceutical companies estimates and forecast 2018 to 2030 (USD Million)
  • 7.5.2. Medical Devices Manufacturers
    • 7.5.2.1. Medical devices manufacturers estimates and forecast 2018 to 2030 (USD Million)
  • 7.5.3. Academic and Government Research Institutes
    • 7.5.3.1. Academic and government research institutes market estimates and forecast 2018 to 2030 (USD Million)
  • 7.5.4. Contract Research Organization (CRO)
    • 7.5.4.1. Contract research organization (CRO) market estimates and forecast 2018 to 2030 (USD Million)
  • 7.5.5. Others
    • 7.5.5.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 8. Clinical Trial Imaging Market: Regional Estimates & Trend Analysis

• 8.1. Regional Market Share Analysis, 2023 & 2030
• 8.2. Regional Market Dashboard
• 8.3. Global Regional Market Snapshot
• 8.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 8.5. North America
  • 8.5.1. U.S.
    • 8.5.1.1. Key country dynamics
    • 8.5.1.2. Regulatory framework/ reimbursement structure
    • 8.5.1.3. Competitive scenario
    • 8.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.2. Canada
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Regulatory framework/ reimbursement structure
    • 8.5.2.3. Competitive scenario
    • 8.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
• 8.6. Europe
  • 8.6.1. UK
    • 8.6.1.1. Key country dynamics
    • 8.6.1.2. Regulatory framework/ reimbursement structure
    • 8.6.1.3. Competitive scenario
    • 8.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.2. Germany
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Regulatory framework/ reimbursement structure
    • 8.6.2.3. Competitive scenario
    • 8.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.3. France
    • 8.6.3.1. Key country dynamics
    • 8.6.3.2. Regulatory framework/ reimbursement structure
    • 8.6.3.3. Competitive scenario
    • 8.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.4. Italy
    • 8.6.4.1. Key country dynamics
    • 8.6.4.2. Regulatory framework/ reimbursement structure
    • 8.6.4.3. Competitive scenario
    • 8.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.5. Spain
    • 8.6.5.1. Key country dynamics
    • 8.6.5.2. Regulatory framework/ reimbursement structure
    • 8.6.5.3. Competitive scenario
    • 8.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.6. Norway
    • 8.6.6.1. Key country dynamics
    • 8.6.6.2. Regulatory framework/ reimbursement structure
    • 8.6.6.3. Competitive scenario
    • 8.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.7. Sweden
    • 8.6.7.1. Key country dynamics
    • 8.6.7.2. Regulatory framework/ reimbursement structure
    • 8.6.7.3. Competitive scenario
    • 8.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.8. Denmark
    • 8.6.8.1. Key country dynamics
    • 8.6.8.2. Regulatory framework/ reimbursement structure
    • 8.6.8.3. Competitive scenario
    • 8.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 8.7. Asia Pacific
  • 8.7.1. Japan
    • 8.7.1.1. Key country dynamics
    • 8.7.1.2. Regulatory framework/ reimbursement structure
    • 8.7.1.3. Competitive scenario
    • 8.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.2. China
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Regulatory framework/ reimbursement structure
    • 8.7.2.3. Competitive scenario
    • 8.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.3. India
    • 8.7.3.1. Key country dynamics
    • 8.7.3.2. Regulatory framework/ reimbursement structure
    • 8.7.3.3. Competitive scenario
    • 8.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.4. Australia
    • 8.7.4.1. Key country dynamics
    • 8.7.4.2. Regulatory framework/ reimbursement structure
    • 8.7.4.3. Competitive scenario
    • 8.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.5. South Korea
    • 8.7.5.1. Key country dynamics
    • 8.7.5.2. Regulatory framework/ reimbursement structure
    • 8.7.5.3. Competitive scenario
    • 8.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.6. Thailand
    • 8.7.6.1. Key country dynamics
    • 8.7.6.2. Regulatory framework/ reimbursement structure
    • 8.7.6.3. Competitive scenario
    • 8.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 8.8. Latin America
  • 8.8.1. Brazil
    • 8.8.1.1. Key country dynamics
    • 8.8.1.2. Regulatory framework/ reimbursement structure
    • 8.8.1.3. Competitive scenario
    • 8.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8.2. Mexico
    • 8.8.2.1. Key country dynamics
    • 8.8.2.2. Regulatory framework/ reimbursement structure
    • 8.8.2.3. Competitive scenario
    • 8.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8.3. Argentina
    • 8.8.3.1. Key country dynamics
    • 8.8.3.2. Regulatory framework/ reimbursement structure
    • 8.8.3.3. Competitive scenario
    • 8.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 8.9. MEA
  • 8.9.1. South Africa
    • 8.9.1.1. Key country dynamics
    • 8.9.1.2. Regulatory framework/ reimbursement structure
    • 8.9.1.3. Competitive scenario
    • 8.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.9.2. Saudi Arabia
    • 8.9.2.1. Key country dynamics
    • 8.9.2.2. Regulatory framework/ reimbursement structure
    • 8.9.2.3. Competitive scenario
    • 8.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.9.3. UAE
    • 8.9.3.1. Key country dynamics
    • 8.9.3.2. Regulatory framework/ reimbursement structure
    • 8.9.3.3. Competitive scenario
    • 8.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.9.4. Kuwait
    • 8.9.4.1. Key country dynamics
    • 8.9.4.2. Regulatory framework/ reimbursement structure
    • 8.9.4.3. Competitive scenario
    • 8.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Recent Developments & Impact Analysis, By Key Market Participants
• 9.2. Company/Competition Categorization
  • 9.2.1. Innovators
• 9.3. Vendor Landscape
  • 9.3.1. List of key distributors and channel partners
  • 9.3.2. Key customers
  • 9.3.3. Key company market share analysis, 2023
  • 9.3.4. IXICO plc
    • 9.3.4.1. Company overview
    • 9.3.4.2. Financial performance
    • 9.3.4.3. Product benchmarking
    • 9.3.4.4. Strategic initiatives
  • 9.3.5. Navitas Life Sciences
    • 9.3.5.1. Company overview
    • 9.3.5.2. Financial performance
    • 9.3.5.3. Product benchmarking
    • 9.3.5.4. Strategic initiatives
  • 9.3.6. Resonance Health
    • 9.3.6.1. Company overview
    • 9.3.6.2. Financial performance
    • 9.3.6.3. Product benchmarking
    • 9.3.6.4. Strategic initiatives
  • 9.3.7. ProScan Imaging
    • 9.3.7.1. Company overview
    • 9.3.7.2. Financial performance
    • 9.3.7.3. Product benchmarking
    • 9.3.7.4. Strategic initiatives
  • 9.3.8. Radiant Sage LLC
    • 9.3.8.1. Company overview
    • 9.3.8.2. Financial performance
    • 9.3.8.3. Product benchmarking
    • 9.3.8.4. Strategic initiatives
  • 9.3.9. Medpace
    • 9.3.9.1. Company overview
    • 9.3.9.2. Financial performance
    • 9.3.9.3. Product benchmarking
    • 9.3.9.4. Strategic initiatives
  • 9.3.10. Biomedical Systems Corp.
    • 9.3.10.1. Company overview
    • 9.3.10.2. Financial performance
    • 9.3.10.3. Product benchmarking
    • 9.3.10.4. Strategic initiatives
  • 9.3.11. Cardiovascular Imaging Technologies
    • 9.3.11.1. Company overview
    • 9.3.11.2. Financial performance
    • 9.3.11.3. Product benchmarking
    • 9.3.11.4. Strategic initiatives
  • 9.3.12. Intrinsic Imaging
    • 9.3.12.1. Company overview
    • 9.3.12.2. Financial performance
    • 9.3.12.3. Product benchmarking
    • 9.3.12.4. Strategic initiatives
  • 9.3.13. BioTelemetry
    • 9.3.13.1. Company overview
    • 9.3.13.2. Financial performance
    • 9.3.13.3. Product benchmarking
    • 9.3.13.4. Strategic initiatives